+44 (0)1509 263171
Please use this identifier to cite or link to this item:
|Title: ||The use of colour on the labelling of medicines|
|Authors: ||Filik, Ruth|
Gale, Alastair G.
|Issue Date: ||2005|
|Publisher: ||© Shaker Publishing|
|Citation: ||FILIK, R., PURDY, K. and GALE, A.G., 2005. The use of colour on the labelling of medicines. IN: DE WAARD ... et al (eds), Human Factors in Design, Safety and Management. Aachen: Shaker|
|Abstract: ||Medication errors occur as a result of a breakdown in the overall system of prescribing,
dispensing, and administration of a drug. Problems with packaging and labelling can be thought of as being latent conditions in the system that can predispose to errors during dispensing and administration. Errors often arise through different strengths of the same product and different products from the same manufacturer having similar packaging. One possible way to aid to product differentiation is to use colour, however, whether or not colour is an appropriate aid to the correct identification of a product is a controversial issue. We present a series of visual search studies investigating the use of colour on drug labelling as a systems change to aid the identification of drug products. Participants were given the task of searching for a target drug product amongst a range of products. In some trials colour could be used as a cue to product identification. Findings provide support for the judicious, or unambiguous use of colour on the packaging and labelling of medicines; participants made fewer errors when colour was an unambiguous cue to identity, but made more errors when similar products were also the same colour.|
|Description: ||This is a book chapter.|
|Appears in Collections:||Book Chapters (Design School)|
Files associated with this item:
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.